From: Clinical and lung function outcomes in a cohort of children with severe asthma
Severe Asthma | First Visit | Follow-up | Â |
---|---|---|---|
 | n = 16 Mean/median (SD/min-max) | n = 16 Mean/median (SD/min-max) | p value |
FVC litres pre BD | 2.5/2.6 (0.6/1.6–3.7) | 3.7/3.4 (1.3/1.4–6.7) | 0.0002 |
FVC % pre BD | 92.2/95.5 (13.1/64–109) | 100.6/101 (10.2/81/114) | 0.053 |
FEV1 litres pre BD | 1.7/1.7 (0.4/1.1–2.5) | 2.7/2.1 (0.9/1.2–4.9) | < 0.0001 |
FEV1% pre BD | 69.8/71.5 (14.4/40–91) | 84.1/85 (10.9/59–107) | 0.0009 |
Abnormal FEV1% pre BD | 10(63) | 5(31) | 0.077 |
FEV1/FVC litres pre BD | 66.9/67.3 (8.7/47.7–88.4) | 75.3/74.0 (8.4/64.7–95.3) | 0.002 |
FVC litres post BD | 2.6/2.7 (0.6/1.6–3.9) | 3.8/3.5 (1.3/1.5–6.8) | 0.0002 |
FVC % post BD | 97.7/102 (12.1/75–117) | 103.5/105 (9.6/84–116) | 0.136 |
FEV1 litres post BD | 1.8/1.8 (0.4/1.2–2.7) | 2.9/2.9 (1.0/1.3–5.6) | 0.0003 |
FEV1% post BD | 78.5/71.2 (13.7/47–98) | 89.9/92 (13.2/66–118) | 0.006 |
FEV1/FVC litres post BD | 71.2/72.3 (9.3/55.7–92.9) | 76.5/76.2 (10.6/54–98.3) | 0.073 |
BDR % | 13/8 (13/3–45) | 8/6 [7.7/(−4)-23] | 0.224 |
BDR ≥ 12%a | 5(31) | 6(38) | 0.710 |
ACT scoreb | 14/12 (5/8–25) | 18/18 (5/12–25) | 0.009 |
Percentage of ACT score ≤ 19a | 12(75) | 9(56) | 0.264 |
TLC% | 117/113 (24/88–184) | 105/104 (13/86–140) | 0.094 |
TLC litres | 4/4 (1/3–6) | 11/5 (24/2–101) | 0.262 |
RV/TLC % | 171/181 (40/112–254) | 131/130 (32/77–199) | < 0.0001 |
Abnormal RV/TLC% | 12(75) | 5(31) | 0.013 |
 | n = 6 Mean/median (SD/min-max) | n = 6 Mean/median (SD/min-max) |  |
LCI | 11.0/10.7 (1.7/8.6–13.6) | 9.5/8.5 (2/7.2–12.8) | 0.237 |
Abnormal LCI (%)a | 6(100) | 5(83) | 0.297 |
FRC/body weight (mL/kg) | 51.9/52.9 (10.5/38–62.3) | 58.4/59.5 (17.9/34–79.9) | 0.104 |
FeNO (ppb)b | 30/19 (26/6–87) | 36/31 (33/4–100) | 0.390 |
Abnormal FeNOa | 5(42)b | 6(50)b | 0.682 |